Recent Headlines
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative BioMart
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative BioMart
Boulder Firm Ensures Availability of All-Natural Pain Patch in the United States
MOTTO USA named distributor for the Motto brand all-natural pain patch in the United States. - August 28, 2014 - MOTTO USA
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative BioMart
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative BioMart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative BioMart
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative BioMart
Within3 Partners with Ashfield Healthcare Communications
Within3 has announced a partnership with Ashfield Healthcare Communications to provide an enhanced suite of services for both organizations. - June 22, 2014 - Within3
UCR (Uppsala Clinical Research Center) Selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process
Uppsala Clinical Research Center (UCR), a top Academic Research Organization based in Sweden, adopted Ethical eAdjudication® cloud-based platform to manage the central assessment of Clinical Trial Endpoints by an independent CEC (Clinical Endpoint Classification) Committee. - June 21, 2014 - Ethical GmbH
Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert
The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding
Within3 Partners with DHC for Better Healthcare Solutions
Within3 has announced its partnership with the Digital Health Coalition (DHC). This strategic partnership creates business value for both organizations. - May 08, 2014 - Within3
BiologicsCorp Launches Supernatant Protein Expression Service
BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp
Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product
Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.
Creative Biomart Launches New Services: Protein Labeling & Conjugation
Creative Biomart has announced the launch of a new offering for protein labeling and conjugation. - March 13, 2014 - Creative BioMart
Dr. Emil J. Haldey to Address Physicians in Field of Podiatric Medicine
Joint Session of American Board of Foot Surgeons and American Association of Medical Foot Specialists to welcome pharmaceutical compounding expert. - February 12, 2014 - HALDEY Pharmaceutical Compounding
EightSpokes Announces the Launch of Their Online Presence
EightSpokes, creators of Enlighten, a SaaS-based commercial excellence platform designed with life science companies in mind, announces the launch of their online presence, EightSpokes.com. The website highlights the “Noble Eightfold Path” that inspired the company’s approach to make work more rewarding. Enlighten adopts proven social collaboration technologies and ideas from industry leaders to put teams and team members at the center of every project’s successful execution. - January 29, 2014 - EightSpokes
Biostratus Corporation Announces Issuance of US Patent for Tissue Bulking and Tissue Generation Technologies
Medical biotechnology company Biostratus Corporation has today announced the issuance of the USPTO Patent #8,586,089 titled "Enhanced Carriers for the Delivery of Microparticles to Mammalian Tissues and Fluids." The Biostratus patent covers a novel class of biocompatible injectable... - January 17, 2014 - Biostratus Corporation
Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants
Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative BioMart
International Polymer Solutions (IPS) Awarded ISO-9001:2008 Certification
ISO-9001:2008 Quality Certification granted to producer of plastic components for pharmaceutical, semiconductor, laboratory and other environments. International Polymer Solutions (IPS) is proud to announce their recent certification. - December 16, 2013 - International Polymer Solutions Inc.
American Regent, Inc. Takes Center Stage on The Balancing Act® Airing on Lifetime Talkshow
Make sure to tune in to The Balancing Act on December 11th and 18th at 7:00 am (ET/PT) as Blood specialist Dr. Lawrence Tim Goodnough, blood disease expert and Lynell D'Sylva, BSN, RN from American Regent explain what IDA is and introduce their innovative treatment option. - December 10, 2013 - American Regent, Inc.
Dr. Emil J. Haldey to Speak Before Medical Society of the State of New York
Dr. Emil J. Haldey, President of New York City-based HALDEY Pharmaceutical Compounding, will speak later this week before an audience of doctors at First District Branch of the Medical Society of the State of New York (MSSNY). MSSNY’s First Branch includes all five boroughs of New York... - November 20, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions
In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative BioMart
Creative Biomart Decides to Pump $300 Million to Strengthen Biosimilar Cell Lines Production
Today on the annual department meeting, Creative BioMart announces that it plans to invest more than $300 million to strengthen its biosimilar cell lines production in global range. The domain sectors of Creative BioMart are recombinant proteins, antibodies and enzymes. Several years ago, the... - November 17, 2013 - Creative BioMart
Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing
Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative BioMart
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative BioMart
HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2
Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative BioMart
International Polymer Solutions Debuts Corporate Video
Video provides overview of company products and services. - September 16, 2013 - International Polymer Solutions Inc.
International Polymer Solutions Launches New Website
TEQCOM and BECO websites merge to form new International Polymer Solutions site. - September 12, 2013 - International Polymer Solutions Inc.
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative BioMart
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative BioMart
Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody
In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative BioMart
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative BioMart
Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users
In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative BioMart
Surgical Face Masks: AdvaCare Detects Rise in Global Demand
AdvaCare has detected a rise in global demand for its surgical face masks. This comes at the same time as recent headlines from Singapore which highlight the problem of pollution in South East Asia, including Indonesia and Malaysia. The market size for surgical face masks has expanded rapidly with individual consumers now becoming more conscious about their health. Medical supplies distributors, such as pharmacies and medical centers, should maintain ample stock of AdvaCare’s surgical face masks - August 01, 2013 - AdvaCare Pharmaceutical
Wescadia Group’s White Paper - Pursuing Growth: Optimizing Business Development Opportunities
Wescadia Group, a healthcare consultancy firm, announces the release of its white paper entitled “Pursuing Growth: Optimizing Business Development Opportunities.” - July 31, 2013 - Wescadia Group Pty Ltd
Creative Biomart Launched Novel Animal-free Recombinant Proteins for Stable Research
The novel animal-free protein production system is more efficient, fast, flexible and cheap compared to transgenic plants recombinant proteins production; the scaling-up compared with bio-reactors is simple and lineal. It doesn't have issues with inclusion bodies as E.coli. - June 28, 2013 - Creative BioMart
Blood Bag Market in Developing Countries (AdvaCare Pharma)
AdvaCare is currently on a campaign to find distributors for Blood Transfusion Bag (Blood Bags) in developing countries. - June 23, 2013 - AdvaCare Pharmaceutical
AdvaCare Announces Two New Products
AdvaCare is once again expanding its lists of products in an effort to better cater to patients and distributors. Sanitary pads and colostomy bags have been added to our existing array of medical supplies. - June 02, 2013 - AdvaCare Pharmaceutical
Creative Biomart Scientists Found That Shutdown Gene Arih2 May Treat Hepatitis
Arih2 was found within the sentinel dendritic cells of the immune system, which play a vital role in defending intruders. - May 31, 2013 - Creative BioMart
Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D
Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative BioMart
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector
Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd
A Preview of AdvaCare’s Monthly Price Updates Newsletter
A Sneak Peak at 3 of Advacare's 7 Top Featured Products - December 16, 2012 - AdvaCare Pharmaceutical
Auto-Disable Syringes: Moving Towards Safer Vaccinations
It is undeniable that needles and syringes continue to be vital tools in numerous areas of healthcare and if used incorrectly, it can lead to often deadly diseases and infections. This happens most commonly with repeated needle use on multiple patients. A study carried by the World and Health... - December 09, 2012 - AdvaCare Pharmaceutical
Ameridose Sponsors Health Connect Partners' 2012 Fall Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its sponsorship of Health Connect Partners’ 2012 Fall Hospital Pharmacy Conference, September 24-26 at the Hyatt Regency in Dallas, Texas. - September 19, 2012 - Ameridose, LLC
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
AdvaCare's New USFDA Approved Medical Disposable Product Line to be Introduced in June 2012
Medical Disposables and Supplies are AdvaCare’s fastest growing product line. - June 13, 2012 - AdvaCare Pharmaceutical
Ameridose Announces Agreement with HealthTrust
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce the signing of a new agreement for providing sterile admixing and repackaging services to HealthTrust Purchasing Group, L.P. (“HealthTrust”) members. - June 05, 2012 - Ameridose, LLC
Foamix Fortifies Its Patent Position in Mexico
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, announced today that the Company has obtained another granted patent in Mexico. - June 05, 2012 - Foamix Ltd